IMS MEDICATION : revenue, balance sheet and financial ratios

IMS MEDICATION is a French company founded 17 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in POISSY (78300), this company of category PME shows in 2019 a revenue of 1.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - IMS MEDICATION (SIREN 511853863)
Indicator 2021 2020 2019 2018 2017 2016
Revenue N/C N/C 1 350 019 € 1 341 152 € 1 239 500 € 876 035 €
Net income -290 721 € 113 936 € 63 922 € 8 185 € 111 425 € -105 749 €
EBITDA N/C N/C 152 403 € 107 696 € 200 868 € -26 081 €
Net margin N/C N/C 4.7% 0.6% 9.0% -12.1%

Revenue and income statement

In 2021, IMS MEDICATION records a net loss of 291 k€. This deficit will reduce equity on the balance sheet.

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-290 721 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 146%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 26%. The balance between equity and debt is satisfactory.

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

145.854%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

25.744%

Asset age ratio (2021) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

76.7%

Solvency indicators evolution
IMS MEDICATION

Sector positioning

Debt ratio
145.85 2021
2019
2020
2021
Q1: 0.0
Med: 8.28
Q3: 63.33
Average

In 2021, the debt ratio of IMS MEDICATION (145.85) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
25.74% 2021
2019
2020
2021
Q1: 16.51%
Med: 37.11%
Q3: 57.43%
Average

In 2021, the financial autonomy of IMS MEDICATION (25.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
1.92 years 2019
2019
Q1: 0.0 years
Med: 0.0 years
Q3: 1.29 years
Average

In 2019, the repayment capacity of IMS MEDICATION (1.92) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 98.10. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

98.098

Liquidity indicators evolution
IMS MEDICATION

Sector positioning

Liquidity ratio
98.1 2021
2019
2020
2021
Q1: 139.0
Med: 204.34
Q3: 325.42
Watch

In 2021, the liquidity ratio of IMS MEDICATION (98.10) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
1.57x 2019
2019
Q1: 0.0x
Med: 0.14x
Q3: 4.04x
Good

In 2019, the interest coverage of IMS MEDICATION (1.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2021) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2021) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2021) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2021) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
IMS MEDICATION

Positioning of IMS MEDICATION in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare IMS MEDICATION with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about IMS MEDICATION

What is the revenue of IMS MEDICATION ?

The revenue of IMS MEDICATION in 2019 is 1.4 M€.

Is IMS MEDICATION profitable?

IMS MEDICATION recorded a net loss in 2021.

Where is the headquarters of IMS MEDICATION ?

The headquarters of IMS MEDICATION is located in POISSY (78300), in the department Yvelines.

Where to find the tax return of IMS MEDICATION ?

The tax return of IMS MEDICATION is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does IMS MEDICATION operate?

IMS MEDICATION operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.